Login to Your Account



BioCryst Out-Licenses BCX-4208 To Roche In Potential $560M Deal

By Aaron Lorenzo


Thursday, December 1, 2005
The holiday season is coming early to BioCryst Pharmaceuticals Inc., which could earn more than half a billion dollars per terms of a just-announced licensing deal with F. Hoffmann-La Roche Ltd. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription